Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Heather A. Parsons; Timothy Blewett; Xiangying Chu; Sainetra Sridhar; Katheryn Santos; Kan Xiong; Vandana G. Abramson; Ashka Patel; Ju Cheng; Adam Brufsky; Justin Rhoades; Jeremy Force; Ruolin Liu; Tiffany A. Traina; Lisa A. Carey; Mothaffar F. Rimawi; Kathy D. Miller; Vered Stearns; Jennifer Specht; Carla Falkson; Harold J. Burstein; Antonio C. Wolff; Eric P. Winer; Nabihah Tayob; Ian E. Krop; G. Mike Makrigiorgos; Todd R. Golub; Erica L. Mayer; Viktor A. Adalsteinsson

doi:10.1101/2023.03.06.23286772

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

View ORCID ProfileHeather A. Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ashka Patel, Ju Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Ruolin Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer Specht, Carla Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson

doi: https://doi.org/10.1101/2023.03.06.23286772

Heather A. Parsons

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

3Harvard Medical School, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Heather A. Parsons
For correspondence: Heather_Parsons@dfci.harvard.edu Erica_Mayer@dfci.harvard.edu viktor@broadinstitute.org

Timothy Blewett

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiangying Chu

5Data Science, Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sainetra Sridhar

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katheryn Santos

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kan Xiong

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vandana G. Abramson

6Vanderbilt-Ingram Cancer Center, Nashville, TN, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ashka Patel

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ju Cheng

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adam Brufsky

7University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Justin Rhoades

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremy Force

8Duke Cancer Center, Durham, NC, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ruolin Liu

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tiffany A. Traina

9Memorial Sloan Kettering Cancer Center, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lisa A. Carey

10The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mothaffar F. Rimawi

11Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston, TX, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kathy D. Miller

12Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA; Birmingham, AB, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vered Stearns

13Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jennifer Specht

14Seattle Cancer Care Alliance, Seattle, WA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carla Falkson

15The University of Alabama at Birmingham, Birmingham, AL, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Harold J. Burstein

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

3Harvard Medical School, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Antonio C. Wolff

13Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eric P. Winer

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

3Harvard Medical School, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nabihah Tayob

5Data Science, Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ian E. Krop

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

3Harvard Medical School, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

G. Mike Makrigiorgos

16Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Todd R. Golub

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Erica L. Mayer

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

2Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA

3Harvard Medical School, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Heather_Parsons@dfci.harvard.edu Erica_Mayer@dfci.harvard.edu viktor@broadinstitute.org

Viktor A. Adalsteinsson

4Broad Institute of MIT and Harvard, Boston, MA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Heather_Parsons@dfci.harvard.edu Erica_Mayer@dfci.harvard.edu viktor@broadinstitute.org

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

The data that support the findings of this study are available from the corresponding authors [HAP, ELM, and VAA], upon reasonable request.

View the discussion thread.

PreviousNext

Posted March 08, 2023.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Heather A. Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ashka Patel, Ju Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Ruolin Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer Specht, Carla Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson

medRxiv 2023.03.06.23286772; doi: https://doi.org/10.1101/2023.03.06.23286772

Share This Article: